Heidelberg Innovation

Total investments

10

Average round size

15M

Portfolio companies

7

Rounds per year

0.40

Lead investments

1

Follow on index

0.30

Exits

4

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

Heidelberg Innovation is the famous VC, which was founded in 1997. The leading representative office of defined VC is situated in the Heidelberg. The venture was found in Europe in Germany.

This organization was formed by Ulrich Abshagen.

Among the most popular portfolio startups of the fund, we may highlight Vasopharm, Santhera Pharmaceuticals, Pelikan Technologies. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Health Diagnostics.

This Heidelberg Innovation works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2012. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2005.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Heidelberg Innovation, startups are often financed by Bayern Kapital GmbH, High-Tech Gru00fcnderfonds, Wellington Partners. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, NGN Capital, Mannheim Holdings. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Bayern Kapital GmbH, Wellington Partners.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
10
Lead investments
1
Exits
4
Rounds per year
0.40
Follow on index
0.30
Investments by industry
  • Biotechnology (10)
  • Medical (6)
  • Health Care (4)
  • Pharmaceutical (4)
  • Therapeutics (3)
  • Show 3 more
Investments by region
  • Germany (6)
  • Switzerland (2)
  • United States (2)
Peak activity year
2006

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
76M
Group Appearance index
1.00
Avg. company exit year
10
Avg. multiplicator
2.46

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Santhera Pharmaceuticals 20 Dec 2005 Biotechnology, Health Care, Pharmaceutical Early Stage Venture 18M Switzerland, Basel-Country

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.